Company intelligence / Profile preview

Nanjing Shuangke Pharmaceutical Development

Nanjing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Nanjing Shuangke Pharmaceutical Development Co., Ltd. is a Chinese pharmaceutical research and development company and contract research organization (CRO) founded in 1995. The company specializes in new drug development, generic drug consistency evaluation, technology transfer, and pharmaceutical manufacturing technical services. Its product portfolio and R&D capabilities span multiple therapeutic areas, including ophthalmology, cardiovascular diseases, endocrinology, neurology, anti-infectives, and oncology. Over its history, Nanjing Shuangke has completed more than 200 drug technology developments, securing 37 new drug certificates and over 80 production approvals. Through its subsidiary, Nanjing Maidi Xinze Pharmaceutical Technology Development Co., Ltd., the company provides comprehensive one-stop services covering CMC, pre-BE, and formal BE clinical trials.

Therapeutic areas: Infectious DiseasesGastroenterologyCardiovascularEndocrinologyOphthalmologyOncology
Modalities: Small molecule
Industry: Biotech

Partnerships

Shanghai Pharma Group Xinyi Tianping PharmaceuticalGuangzhou Pharmaceutical Group Guanghua PharmaceuticalChina National Pharmaceutical Group Modern PharmaceuticalBashan Group Wanjie PharmaceuticalRuinian Group Qianjin PharmaceuticalZhejiang MedicineSimcere PharmaceuticalNanjing PharmaceuticalChia Tai Qingjiang PharmaceuticalChina General Sanyo PharmacyChangjiang PharmaceuticalWeite PharmaceuticalKelun PharmaceuticalShenzhen Xianggen Biotechnology Co., Ltd.Raycom Pharmaceutical

Beyond the preview

Go deeper on Nanjing Shuangke Pharmaceutical Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanjing Shuangke Pharmaceutical Development.

Explore the full profile